GI Cancers (ASCO 2024)

GI Cancers (ASCO 2024)

GI Cancers (ASCO 2024) Welcome & introduction by host Thibaud Kössler NEW TREATMENT UPDATES IN UPPER GI ELIZABETH SMYTH LATEST INSIGHTS FOR HCC AND PANCREATIC CANCER SARA DE DOSSO HIGHLIGHTED DATA FROM ASCO FOR CRC THIBAUD KÖSSLER  } 1 h 31 min Get Your CME...
HER2 in Lung, GYNE & GI Cancers

HER2 in Lung, GYNE & GI Cancers

HER2 in Lung, GYNE & GI Cancers Welcome & introduction by host Ilaria Colombo Clinical implications of HER2 in gastrointestinal cancers Florian Lordick Treatment considerations for HER2-positive lung cancer Maximilian Hochmair Latest treatment updates in...
Biomarkers in GI & Lung

Biomarkers in GI & Lung

Biomarkers in GI & Lung The Significance of Biomarkers in GI Oncology for My Therapy Decision Sara De Dosso Biomarkers in GI Oncology: The Tests We Perform in Gastric and GEJ Today Rupert Langer Current Standards in in Lung Cancer Therapy: Which Biomarkers We...
GI Cancers (ASCO 2023)

GI Cancers (ASCO 2023)

GI Cancers (ASCO 2023) Welcome & introduction by host Thibaud Kössler Latest treatment updates in Upper GI Steve Maron Highlighted data for HCC & Pancreatic Cancer Sara De Dosso Highlights from ASCO for CRC Thibaud Kössler  } 1 h 36 min Get Your CME...
HER2 in Breast, Lung & GI Cancers

HER2 in Breast, Lung & GI Cancers

HER2 in Breast, Lung & GI Cancers Welcome & general introduction into HER2 testing Sabina Berezowska HER2 as a biomarker in breast cancer Zsuzsanna Varga Treatment considerations for HER2-positive GI-cancers Florian Lordick Clinical implications of HER2 in lung...